Due to a number of inquires, I will give an update this month on the Zofran litigation. Read more
A decision by the New Jersey Appellate Division has preserved patients’ claims that manufacturers of generic Reglan failed to adequately warn about neurological risks associated with R... Read more
In June, 2011, the United States Supreme Court ruled in Pliva, Inc. v. Mensing that a generic drug manufacturer could not be liable for failing to warn of injuries as a result of taking a ge... Read more
If you would like to subscribe to the Jere Beasley Report digital edition, simply visit our Subscriptions page and provide the necessary information or call us at 800-898-2034.
Attorney Advertising - Prior results do not guarantee a similar outcome.